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Amyotrophic lateral sclerosis (ALS) is a fatal paralytic disorder caused by dysfunction
and degeneration of motor neurons. Multiple disease-causing mutations, including in the
genes for SOD1 and TDP-43, have been identified in ALS. Astrocytes expressing mutant
SOD1 are strongly implicated in the pathogenesis of ALS: we have shown that media
conditioned by astrocytes carrying mutant SOD1G93A contains toxic factor(s) that kill
motoneurons by activating voltage-sensitive sodium (Nav ) channels. In contrast, a recent
study suggests that astrocytes expressing mutated TDP43 contribute to ALS pathology,
but do so via cell-autonomous processes and lack non-cell-autonomous toxicity. Here we
investigate whether astrocytes that express diverse ALS-causing mutations release toxic
factor(s) that induce motoneuron death, and if so, whether they do so via a common
pathogenic pathway. We exposed primary cultures of wild-type spinal cord cells to
conditioned medium derived from astrocytes (ACM) that express SOD1 (ACM-SOD1G93A
and ACM-SOD1G86R) or TDP43 (ACM-TDP43A315T) mutants; we show that such exposure
rapidly (within 30–60min) increases dichlorofluorescein (DCF) fluorescence (indicative of
nitroxidative stress) and leads to extensive motoneuron-specific death within a few days.
Co-application of the diverse ACMs with anti-oxidants Trolox or esculetin (but not with
resveratrol) strongly improves motoneuron survival. We also find that co-incubation of
the cultures in the ACMs with Nav channel blockers (including mexiletine, spermidine, or
riluzole) prevents both intracellular nitroxidative stress and motoneuron death. Together,
our data document that two completely unrelated ALS models lead to the death of
motoneuron via non-cell-autonomous processes, and show that astrocytes expressing
mutations in SOD1 and TDP43 trigger such cell death through a common pathogenic
pathway that involves nitroxidative stress, induced at least in part by Nav channel activity.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal paralytic disor-
der caused by the progressive degeneration of cranial and spinal
motoneurons in adulthood, and leading to death by respira-
tory failure within 3–5 years of diagnosis. Although the majority
of ALS cases are sporadic (SALS), ∼10% are familial (FALS)
and are generated by mutations in at least 15 identified ALS-
associated gene loci (Bento-Abreu et al., 2010; Ferraiuolo et al.,
2011). Dominant mutations in superoxide dismutase 1 (SOD1)
and transactive response DNA-binding protein 43 (TARDBP
gene, TDP43 protein) are common causes of ALS (Cleveland
and Rothstein, 2001; Pasinelli and Brown, 2006; Cozzolino et al.,
2012)—to date, more than 150 SOD1 mutations and 40 TARDBP
mutations are known to be associated with the ALS phenotype
(http://alsod.iop.kcl.ac.uk/; Abel et al., 2012).
Although the molecular underpinnings of motoneuron degen-
eration in ALS have not yet been elucidated, in vivo and in vitro
studies with use of transgenic mice that carry ALS-causing
mutants reveal a large number of pathogenic changes in affected
motoneurons: these include mitochondrial dysfunction, hyperex-
citability, glutamate excitotoxicity, nitroxidative stress from reac-
tive oxygen species (ROS) or reactive nitrogen species (RNS)
(collectively leading to nitroxidative stress), protein aggregation
and misfolding, proteasome impairment, cytoskeletal disruption,
activation of cell death signals, and dysregulation of transcrip-
tion and RNA processing (Beckman et al., 2001; Cleveland and
Rothstein, 2001; Bruijn et al., 2004; Pasinelli and Brown, 2006;
Ferraiuolo et al., 2011; Cozzolino et al., 2012; van Zundert et al.,
2012). Despite these advances in identifying these cellular alter-
ations, however, the origin(s) and interplay between multiple
pathogenic processes of motoneuron death in ALS remain largely
unknown.
A large number of studies highlight the importance of dysreg-
ulated crosstalk between motoneurons and non-neuronal cells in
ALS (Ilieva et al., 2009). The notion that ALS is at least partially
a non-cell-autonomous disease originates in a groundbreaking
study from Clement et al. (2003) who generated chimeric mice
composed of mixtures of normal and SOD1 mutant-expressing
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cells, and showed that wild-type non-neuronal cells extend the
survival of motoneurons carrying mutant SOD1. Additional
research has since firmly established the contribution of “deadly
neighboring cells” (astrocytes, microglia, oligodendrocytes, and
Schwann cells) to the degeneration of motoneurons (Boillée
et al., 2006; Yamanaka et al., 2008a,b; Lobsiger et al., 2009;
Ilieva et al., 2009). Other findings offer compelling evidence
that primary mutant SOD1-expressing astrocytes from mouse
(Di Giorgio et al., 2007; Nagai et al., 2007; Castillo et al., 2013;
Fritz et al., 2013), rat (Vargas et al., 2006; Cassina et al., 2008),
and humans (Marchetto et al., 2008) effectively and selectively
kill motoneurons, but spare interneurons. Importantly, astrocytes
differentiated from neuronal progenitor cells (NPCs) obtained
either from post-mortem spinal cord tissue or from skin biop-
sies from FALS (SOD1 mutations and hexanucleotide expansion
in C9orf72) and SALS patients also display non-cell-autonomous
toxicity, and selectively kill motoneurons in a co-culture model
system (Haidet-Phillips et al., 2011; Meyer et al., 2014). Moreover,
astrocytes that express mutants in SOD1 contribute to the patho-
genesis of ALS by releasing into the media a toxic factor(s) that
kills motoneurons (Nagai et al., 2007; Cassina et al., 2008; Castillo
et al., 2013; Fritz et al., 2013). Little is known regarding the
non-cell- autonomous toxicity mediated by mutants other than
in SOD1, but a recent study suggests that astrocytes express-
ing mutated TDP43 (TDP43M337V) lack non-cell-autonomous
toxicity and contribute to ALS pathology only through cell-
autonomous processes (Serio et al., 2013).
Here we show that conditioned medium derived from astro-
cytes that were harvested from transgenic mice carrying ALS-
causing mutations in SOD1 (SOD1G93A and SOD1G86R) or
TDP43 (TDP43A315T) contain toxic factors that trigger motoneu-
ron death. Based on earlier studies which document the involve-
ment of Nav channel-mediated excitability and nitroxidative
stress in the pathogenesis of ALS (Ferraiuolo et al., 2011;
Cozzolino et al., 2012; van Zundert et al., 2012), we tested here
whether these pathogenic changes are induced in motoneurons
via non-cell-autonomous processes. We demonstrate that they do
so, and our results indicate that nitroxidative stress within the
neurons is mediated by Nav channel activity.
MATERIALS AND METHODS
ANIMALS
Care and use of rodents was in accordance with the US National
InstituteofHealthguidelines,andwasapprovedbytheInstitutional
Animal Care and Use Committee of Andres Bello University.
Hemizygous transgenic mice carrying mutant human SOD1G93A
(high copy number; B6SJL; Cat. No. 002726), wild-type human
SOD1WT(B6SJL;Cat.No.002297),mutantmouseSOD1G86R (FVB
crossed onB6SJL background; Cat. No. 005110), ormutantmouse
TDP43A315T (B6.Cg crossed on C57BL/6J; Cat. No. 010700) were
originally obtained from Jackson Laboratories (BarHarbor, USA).
Non-transgenic littermates and transgenic mice over-expressing
the gene for human SOD1WT were used as controls. Transgenes
were identified by polymerase chain reaction (Wegorzewska et al.,
2009; Castillo et al., 2013; Fritz et al., 2013). The SOD1G93A mice,
but not the hSOD1WT mice, develop signs of neuromuscular
deficits (tremor of the legs and loss of extension reflex of the hind
paws) starting at 3 months of age and have an average lifespan
of 19–21 weeks (Gurney et al., 1994). Mice carrying SOD1G86R
(Ripps et al., 1995) or TDP43A315T (Wegorzewska et al., 2009)
develop similar loss of motor function between 3 and 4 months
and do not survive to the age of 4 months.
CONDITIONED MEDIA PREPARATION
ACM was prepared as described (Nagai et al., 2007; Castillo
et al., 2013; Fritz et al., 2013). Briefly, cultures of astrocytes
were prepared from P1-2 wild-type mice and from transgenic
mice expressing human SOD1G93A, mouse hSOD1G86R, human
SOD1WT, or mouse TDP43A315T. Cultures were maintained
in DMEM (Hyclone, Cat. No. SH30081.02) containing 10%
FBS (Hyclone, Cat. No. SH30071.03; lot ATC31648) and 1%
penicillin-streptomycin (Gibco, Cat. No. 15070-063) at 37◦C
5% CO2. Cultures reached confluence after 2–3 weeks and
contained >95% GFAP+ astrocytes. Residual microglia were
removed by shaking cultures in an orbital shaker (200 r.p.m. in the
incubator) overnight (7 h), at which point media was replaced by
spinal culture media (see below). After 7 days, ACMwas collected,
centrifuged (500 g for 10min) and stored at −80◦C; before use,
it was supplemented with 4.5mg/ml D-glucose (final concentra-
tion) and penicillin/streptomycin, and filtered. A chick hindlimb
muscle extract was also added to the ACM before use (Sepulveda
et al., 2010).
For all experiments the ACM was diluted 8–10-fold. The exact
dilution was determined for each new batch of ACM by com-
paring the motoneuron toxicity of the ACM from transgenic
animals carrying the ALS-causing mutants (ACM-SOD1G93A,
ACM-SOD1G86R, and ACM-TDP43A315T) to that of ACM gen-
erated from mice carrying the wild-type human SOD1 gene
(ACM-SOD1WT) or from non-transgenic littermates (ACM-NT-
Control); at the selected dilutions the conditioned media derived
from the astrocytes expressing the ALS-causing genes robustly
killed motoneurons, whereas the ACM-NT-Control and ACM-
SOD1WT did not affect motoneuron survival. The ACM was
applied to ventral spinal cord cultures derived from rats because
better quality motoneurons are obtained from rats than from
mice; a number of studies have shown that such mixed species
co-cultures (from rat, mice, human) do not appear to induce any
side effects (e.g., Pehar et al., 2004; Di Giorgio et al., 2007; Nagai
et al., 2007; Castillo et al., 2013; Fritz et al., 2013).
PRIMARY SPINAL CORD NEURONAL CULTURES
Pregnant Sprague–Dawley rats were deeply anesthetized with
CO2, and primary spinal cultures were prepared from E14 pups
(Sepulveda et al., 2010; Castillo et al., 2013; Fritz et al., 2013).
Briefly, whole spinal cords were excised and placed into ice-cold
HBSS (Gibco, Cat. No. 14185-052) containing 50μg/ml peni-
cillin/streptomycin (Gibco, Cat. No. 15070-063). The dorsal part
of the spinal cord was removed using a small razor blade, and
the ventral cord was minced and enzymatically treated by incu-
bating in pre-warmed HBSS containing 0.25% trypsin (Gibco,
Cat. No. 15090-046) for 20min at 37◦C. Cells were transferred
to a 15ml tube containing neuronal growth media containing
70% MEM (Gibco, Cat. No. 11090-073), 25% Neurobasal media
(Gibco, Cat. No. 21103-049), 1% N2 supplement (Gibco, Cat.
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No. 17502-048), 1% L-glutamine (Gibco, Cat. No. 25030-081),
1% penicillin-streptomycin (Gibco, Cat. No. 15070-063), 2%
horse serum (Hyclone, Cat. No. SH30074.03; lot AQH24495) and
100mM sodium pyruvate (Gibco, Cat. No. 11360-070); they were
precipitated, transferred to a new 15-ml-tube containing 2ml
of growth media, re-suspended by mechanical agitation through
fire-polished glass Pasteur pipettes of different tip diameters, and
counted; 1 × 106 cells were plated on freshly prepared poly-L-
lysine-coated 24-well plates (1mg/ml; 30.000–70.000mW; Sigma,
Cat. No. P2636). Cells were cultured for 7 days at 37◦C under
5% CO2, and supplemented with 45μg/ml chick hindlimb mus-
cle extract (Sepulveda et al., 2010); the media was refreshed every
3 days.
PHARMACOLOGICAL TREATMENTS IN CULTURE
Mexiletine (Tocris, Cat. No. 2596) was dissolved in water to
100mM and used at final concentration of 25 nM. Riluzole
(Sigma, Cat. No. R116) was dissolved in distilled water (plus 10%
Tween20) at 100μM, and added to cultures to final concentration
of 100 nM. Spermidine (Sigma, Cat. No. S2626) was dissolved in
water at 100mg/ml and added to cultures to a final concentra-
tion of 10μM. Trolox (Sigma, Cat. No. 238813) was dissolved in
distilled water at 100mM and added to cultures to final concen-
tration of 1μM. Esculetin (Sigma, Cat. No. 17795) was dissolved
in dimethyl sulfoxide (DMSO), and added to cultures to final
concentration 25μM. Resveratrol (Tocris, Cat. No. 1418) was dis-
solved in DMSO (Sigma) at 100mMand added to cultures to final
concentration of 1μM. All stock solutions were stored at −20◦C.
CELL LABELING AND COUNTING
Motoneurons and interneurons were immunolabeled and
counted as previously described (Sepulveda et al., 2010; Castillo
et al., 2013; Fritz et al., 2013). Briefly, primary spinal cultures
were fixed at 7DIV with 4% paraformaldehyde, and immunos-
tained with an antibody against MAP2 (1:400; Santa Cruz
Biotechnology) to label all neurons (interneurons plus motoneu-
rons) and with the SMI-32 antibody (1:1,000, Sternberger
Monoclonals) to reveal the presence of unphosphorylated
neurofilament-H, which is expressed specifically in motoneu-
rons in spinal cord cultures (Urushitani et al., 2006; Nagai
et al., 2007); antibody binding was visualized with the appro-
priate fluorescent secondary antibodies. Our wild-type primary
spinal cord cultures typically contain at least 6–10%motoneurons
until 12DIV (Sepulveda et al., 2010). Immunolabeled neurons
were documented on an inverted Nikon Eclipse Ti-U microscope
equipped with a SPOT Pursuit™ USB CameraCCD (14-bit), Epi-
fl Illuminator, mercury lamp, and Sutter Smart-Shutter with a
lambda SC controller. Cells were photographed using a 20×
objective; MAP2- and SMI-32-positive neurons were counted
offline within 20 randomly chosen fields, and the percentage of
SMI-32-positive motoneurons within the total number of MAP2-
positive cells was calculated. Each condition was replicated in at
least 3 independent cultures, and in duplicate.
NITROXIDATIVE STRESS MEASUREMENTS WITH CM-H2DCF-DA
The intracellular levels of ROS/RNS were measured with CM-
H2DCF-DA (Invitrogen, Cat. No. C6827). H2DCF-DA is not
a specific probe for a particular oxidant and has been used to
monitor certain ROS/RNS (see Discussion). The CM-H2DCF-DA
stock solution (5mM) was prepared in DMSO and was diluted in
the culture medium to a final concentration of 1μM just before
addition to the cells. After application of the diverse ACMs to the
spinal cord cultures for different time (minutes-hours-days), cells
were washed (PBS 1×) to remove the ACMs and exposed to CM-
H2DCF-DA for 30min at 37◦C in dark, to label bothmotoneurons
and interneurons. To facilitate the CM-H2DCF-DA membrane
penetration, 0.004% Pluronic acid F-127 (Invitrogen, Cat. No.
P-3000MP) was added to the culture medium to facilitate dye
entry, eliminating possible hydrolysis of dyes by external esterases
and maintain better cell integrity (Appaix et al., 2012). After the
incubation time, the CM-H2DCF-DA-cointaing culture medium
was removed and cultures were washed twice with PBS 1× and
suspended in culture medium (500μl final volume). Next, cells
were immediately imaged using an inverted Nikon Eclipse Ti-U
microscope equipped with a SPOT Pursuit™ USB CameraCCD
(14-bit), Epi-fl Illuminator, mercury lamp, and Sutter Smart-
Shutter with a lambda SC controller. Cells were photographed
using a 20× objective. As CM-H2DCF-DA is a non-fluorescent
dye it passively diffuses into cells and is hydrolyzed intracellularly
to the DCFH carboxylate anion that is trapped inside; oxidation
of DCFH results in the formation of the fluorescent product
DCF, with excitation and emission wavelengths λex/λem = 492–
495/517–527 nm. The exposure time was kept below 4 s in order
to avoid photo-oxidation of the ROS/RNS sensitive dye and for all
given treatments fields were exposed for exactly the same amount
of time. At least three independent fields were acquired for each
condition and at least 10 cells per fieldwere used for quantification
of the fluorescence signal. Cells were marked by drawing a region
of interest around the cell body, and mean fluorescence intensity
was calculated for each cell after subtraction of the background
signal using the image analysis module in ImageJ software. Those
cells with a relative intensity unit (RIU) of ≥1.5 were counted as
positive. Cultures were also incubated with H2O2 (200μM for
20min) to serve as a positive control and to normalize the number
of DCF-positive cells after ACM application.
DATA ANALYSIS
ANOVA, followed by post-hoc Tukey tests, was used to detect
significant changes. Student’s t-tests were used to compare the
response of two cell populations to individual treatments. Unless
otherwise stated, error bars represent the mean ± s.e.m.; ∗p <
0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. control.
RESULTS
ACM-SOD1G93A, ACM-SOD1G86R, OR ACM-TDP43A315T TRIGGERS
DEATH OF CULTURED PRIMARY MOTONEURONS
Here we investigated whether astrocytes expressing diverse ALS
causing mutants release toxic factor(s) that induce motoneu-
ron death, and if so, whether a common pathogenic pathway
is involved. Astrocyte conditioned media (ACM) was derived
from astrocytes that were harvested from mice carrying mutant
SOD1 (ACM-SOD1G93A and ACM-SOD1G86R) or TDP43 (ACM-
TDP43A315T). These media were added at 8–10-fold dilutions
(see Materials and Methods) to wild-type primary rat spinal
cultures at 4DIV for 3 days; effects on neuron survival were
assessed at 7DIV (Figure 1A). To define the presence of all
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 24 | 3
Rojas et al. Nav -channel activity and ROS/RNS in ALS models
neurons, an antibody against microtubule-associated protein 2
(MAP2) was used (Figure 1B; arrowhead); motoneurons were
specifically identified with use of the SMI-32 antibody, which rec-
ognizes unphosphorylated neurofilament-H (Figure 1B; arrow),
as previously described (Urushitani et al., 2006; Nagai et al.,
2007; Sepulveda et al., 2010; Castillo et al., 2013; Fritz et al.,
2013). Chronic (3 days) exposure (from 4 to 7DIV) of
spinal cultures to ACM-SOD1G93A, ACM-SOD1G86R, or ACM-
TDP43A315T induced ∼50% motoneuron death (Figures 1C,D).
The number of interneurons was unchanged after application
of ACM-SOD1G93A (91 ± 1% vs. control, p > 0.05 by t-test),
ACM-SOD1G86R (96 ± 19% vs. control, p > 0.05 by t-test), or
ACM-TDP43A315T (103 ± 23% vs. control, p > 0.05 by t-test).
Our findings that ACM-SOD1G93A and ACM-SOD1G86R robustly
reduces motoneuron cell survival, while sparing interneurons, are
consistent with previous studies (Nagai et al., 2007; Castillo et al.,
2013; Fritz et al., 2013). Our results with ACM-TDP43A315T also
show for the first time that astrocytes carrying a TDP43 mutant
kill motoneurons through non-cell-autonomous processes.
Three types of control media were used throughout this work.
(1) “Control” media that was not conditioned by astrocytes. (2)
“ACM-NT-Control” media derived from astrocytes that were har-
vested from littermate mice that were negative for the SOD1 and
TDP43 gene. (3) “ACM-SOD1WT” media derived from astrocytes
that were harvested from transgenic mice carrying the non-
pathological human wild-type SOD1 gene. None of these media
caused motoneuron death (Figure 1E). In particular, the finding
that ACM-SOD1WT was not toxic indicates that the factor induc-
ing motoneuron death is specifically due to the SOD1G93A or
SOD1G86R mutation, rather than to overexpression of the human
SOD1 protein. By contrast, we can not exclude the possibility
that motoneuron death in our spinal cultures is attributable, at
least in part, by increased levels of the TDP43 protein itself. In
fact, accumulating data with transgenic models have established
that excessive levels of even human wild-type TDP43 result in
neurodegeneration, likely as a result in the disruption of RNA
metabolism (Wegorzewska et al., 2009;Wils et al., 2010; Igaz et al.,
2011; Ling et al., 2013).
ACM-SOD1G93A, ACM-SOD1G86R, OR ACM-TDP43A315T LEADS TO
INCREASES IN INTRACELLULAR ROS/RNS LEVELS
Increased intracellular levels of nitroxidative stress are widely
and consistently observed in ALS patients, and in in vitro and
in vivo mouse models that express SOD1 mutants (Barber
and Shaw, 2010). To investigate whether soluble toxic factors
released by astrocytes that carry SOD1 and TDP43 mutants
induce an oxidative burden in primary neurons, we exposed
4DIV cultures to the diverse ACMs for 30–120min, washed
cells to remove the ACMs, and subsequently loaded the cells
with CM-H2DCF-DA for 30min (Figure 2A). CM-H2DCF-DA
is a non-fluorescent dye that passively diffuses into cells and
is hydrolyzed intracellularly to the DCFH carboxylate anion
that is trapped inside; oxidation of DCFH results in the for-
mation of the fluorescent product DCF. Increased intensity in
fluorescent DCF could thus reflect detection of certain reac-
tive oxygen and nitrogen species, inducing nitroxidative stress.
Combined real-time fluorescence and phase-contrast imaging
FIGURE 1 | Exposure of primary spinal cord cultures to astrocyte
conditioned media (ACM) derived from SOD1G93A, SOD1G86R, and
TDP43A315T expressing mice triggers death of motoneurons. (A) Flow
diagram of experiment. Primary wild-type (WT) rat spinal cord cultures
(4DIV) were exposed for 3 days to ACM derived from transgenic mice
overexpressing SOD1G93A (ACM-SOD1G93A), SOD1G86R (ACM-SOD1G86R),
or TDP43A315T (ACM-TDP43A315T). Cells were fixed at 7DIV, and cell
survival was assayed with immunocytochemistry. (B) Fixed 7DIV spinal
cord cultures were double-labeled with anti-microtubule-associated
(Continued)
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FIGURE 1 | Continued
protein 2 (MAP2) antibody (red) to visualize interneurons (arrowhead) and
with the SMI-32 antibody (green) to identify motoneurons (arrow). Scale
bar, 25μm. (C) Representative images of MAP2+/SMI32+-labeled neurons
in spinal cultures under control conditions (top image) or treated with the
three different ACMs, as indicated in the figure. Scale bar, 200μm. (D)
Graph showing the percentage of motoneurons that survived after
treatment with ACMs derived from SOD1G93A, SOD1G86R, and TDP43A315T
astrocytes, relative to motoneurons from sister cultures treated with
control medium. (E) Graph showing the percentage of motoneurons that
survived after treatment with media derived from mouse littermates that
were negative for the mutated forms of SOD1 and TDP43
(ACM-NT-Control), or with media derived from transgenic mice carrying the
non-pathological human wild-type SOD1 gene (ACM-SOD1WT). Survival is
shown relative to cultures treated with control media. Values represent
mean ± s.e.m. from at least 3 independent experiments performed in
duplicate, analyzed by One-Way ANOVA followed by a Tukey post-hoc test.
∗∗∗P < 0.001 relative to control medium at 7DIV.
showed that DCF levels were very low under basal culture con-
ditions, while application of ACM-SOD1G93A induced both a
gradual increase in the intensity and the number of neurons
displaying intracellular DCF fluorescence in spinal cord cul-
tures; the fluorescence reached a peak at 30min (Figure 2B).
This increase was mimicked by H2O2 (Figure 2B; 200μM for
20min) but was blocked by use of diverse general anti-oxidants
(see Figure 4). In control experiments, application of ACM-
SOD1WT did not change DCF fluorescence over the same expo-
sure times (Figure 2B2). Exposure of spinal cord cultures to either
ACM-SOD1G86R (Figure 2C) or ACM-TDP43A315T (Figure 2D)
also triggered a gradual increase of intracellular DCF fluores-
cence in neurons; this fluorescence peaked at 60 and 30min,
respectively. Treatment of neuronal cultures with either ACM-
NT-Control (Figures 2C2–D2) or control media did not induce
significant differences (see Supplementary Figure 1 for images
of all controls). Together, these results indicate that toxic fac-
tors released by astrocytes that carry diverse ALS-causing mutants
results in increased nitroxidative stress in spinal cord neu-
rons. The increased nitroxidative stress, however, is unable to
induce immediate cell death as the number of motoneurons
only starts to significantly reduce after 24 h of ACM application
(Supplementary Figure 2).
ANTI-OXIDANTS PREVENT MOTONEURON DEATH INDUCED BY
ACM-SOD1G93A, ACM-SOD1G86R, OR ACM-TDP43A315T
To determine whether the increased nitroxidative stress induced
by the diverse ACMs contributes to motoneuron cell death,
4DIV spinal cord neurons were chronically incubated in a com-
bination of the toxic media plus one of the following anti-
oxidants: Trolox, esculetin or resveratrol (Figure 3A). These
anti-oxidants are reported to reduce intracellular levels of
ROS/RNS (also documented in the present study—see Figure 4
for effects on DCF fluorescence; also see reference citations
below). Multiple doses (ranging from 100 nM to 100μM) of
the anti-oxidants were used to assess the survival of motoneu-
rons under control conditions, and after co-application with
ACM-SOD1G93A (see Supplementary Table 1). For each anti-
oxidant drug, the maximum effect in preventing motoneuron
death induced by ACM-SOD1G93A is displayed in Figure 3B;
the same concentrations of anti-oxidants were also used to test
whether they could rescue motoneuron death induced by ACM-
SOD1G86R (Figure 3C) or ACM-TDP43A315T (Figure 3D) (see
below for details on each anti-oxidant). We also applied these
doses of anti-oxidants to cultures incubated with ACM-SOD1WT
and found that none of the anti-oxidants were successful in sig-
nificantly increasing the number of motoneurons (Figure 3E);
similar results were obtained when anti-oxidants were co-applied
to spinal cord culture with control media or ACM-NT-Control
(not shown), indicating that the beneficial effects of these com-
pounds are specifically attributable to counterbalancing increased
nitroxidative stress induced by the diverse toxic ACMs, rather
than to simply increasing overall motoneuron cell survival in the
cultures.
We first analyzed use of vitamin E, the most potent natu-
rally occurring scavenger of reactive oxygen and nitrogen species
known (Tucker and Townsend, 2005). Extensive studies in ALS
patients and mice models have shown, however, that vitamin
E application in vivo is not capable of significantly prolonging
survival (Gurney et al., 1996; Desnuelle et al., 2001; Ascherio
et al., 2005; Graf et al., 2005) These disappointing results are
likely related to the findings that vitamin E poorly penetrates
the blood-brain barrier, leading to insufficient doses of this
anti-oxidant in the central nervous system; IC50 of vitamin
E is between 1.5 and 59μM while ventricular CSF concen-
tration of this vitamin was found at 0.114μM (reviewed in
Barber and Shaw, 2010). Here we opted to use Trolox, a water-
soluble vitamin E analog that neutralizes ROS (Ghiselli et al.,
1995; Khaldy et al., 2000; Barber et al., 2009; Distelmaier et al.,
2012). Chronic co-application of ACM-SOD1G93A (Figure 3B)
or ACM-TDP43A315T (Figure 3D) with 1μM of Trolox sig-
nificantly improved motoneuron survival. In the spinal cord
cultures treated with ACM-SOD1G86R plus Trolox improve-
ment of motoneurons survival was even better and comparable
with motoneuron survival obtained under control conditions
(Figure 3C).
Next we analyzed esculetin and resveratrol, two molecules
that have anti-oxidant activities (Lin et al., 2000; Kaneko et al.,
2003; Baur and Sinclair, 2006; Barber et al., 2009). Esculetin and
resveratrol were also identified from a screen of the Spectrum
Collection library (consisting of 2000 small compounds) as two
of the best-hit molecules, based on their ability to function
as effective anti-oxidants by reducing DCF fluorescence and
to increase the viability of a mutant SOD1G93A-expressing cell
line; moreover, in silico analysis predicted that these two com-
pounds have specific biochemical properties that allow efficient
blood-brain barrier penetration (Barber et al., 2009). We found
that chronic co-application of ACM-SOD1G93A (Figure 3B) or
ACM-TDP43A315T (Figure 3D) with 25μM esculetin signifi-
cantly improved the survival of motoneurons and, in fact, treat-
ment of spinal cord neurons with esculetin plus ACM-SOD1G86R
enhanced motoneuron survival to the level obtained under con-
trol conditions (Figure 3C).
By contrast, chronic application of resveratrol at 1μM
(Figure 3B)—as well as at a wide range of concentrations
(100 nM to 10μM) (Supplementary Table 1)—failed to prevent
motoneuron death induced by ACM-SOD1G93A. Co-application
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 24 | 5
Rojas et al. Nav -channel activity and ROS/RNS in ALS models
FIGURE 2 | Exposure of primary spinal cord cultures to ACM-SOD1G93A,
ACM-SOD1G86R, and ACM-TDP43A315T induces rapid increases in
intracellular dichlorofluorescein (DCF) fluorescence. (A) Flow diagram of
experiment. Primary wild-type spinal cultures (4DIV) were exposed for
0–120min with the different ACMs (solid lines), washed to remove the ACMs
(filled circles), and loaded for 30min with the fluorescent membrane
permeable ROS/RNS probe CM-H2DCF-DA (dotted lines). Next cultures were
washed and DCF measurements were immediately performed (filled
triangles). (B–D) Cultures exposed to ACM-SOD1G93A (B), ACM-SOD1G86R
(C), or ACM-TDP43A315T (D). (B1–D1) The negatives of representative DCF
fluorescent images (in which both motoneurons and interneurons are
marked) and corresponding phase contrast images of spinal cord cultures
photographed at 0, 30, 90 and 120min after application of ACM-SOD1G93A
(Continued)
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FIGURE 2 | Continued
(B1), ACM-SOD1G86R (C1), or ACM-TDP43A315T (D1) are shown. In all
experiment, H2O2 (200μM for 20min) served as positive control and to
normalize the number of DCF-positive cells after ACM application. Scale bar,
200μm. (B2–D2) Graphs showing the percentage of DCF fluorescent cells
(including both motoneurons and interneurons) under the conditions
indicated. Results obtained with different controls are included in the
graphs: control media, ACM-NT-Control, and ACM-SOD1WT. DCF
fluorescence is relative to cultures treated with H202 (100%). Note that
DCF fluorescence peaked after 30min of incubation of spinal cultures with
ACM-SOD1G93A and ACM-TDP43A315T (B2,D2), and after 60min for
incubation with ACM-SOD1G86R (C2). Values represent mean ± s.e.m.
from at least 3 independent experiments performed in duplicate, analyzed
by t-test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. control.
of 1μM resveratrol also did not significantly improve sur-
vival of motoneurons incubated with either ACM-SOD1G86R
(Figure 3C) or ACM-TDP43A315T (Figure 3D). This negative
effect was not related to toxicity of this anti-oxidant, as over-
all motoneuron cell survival in cultures treated with resver-
atrol was similar to that achieved under control conditions
or cultures treated with ACM-SOD1WT (see Figure 3E and
Supplementary Table 1).
As discussed before, the application of the diverse ACMs
to spinal cord cultures resulted in a strong DCF signals at
30–60min which then gradually reduced (Figure 2). However,
this is only a transient reduction and cells start to steadily
increase DCF fluorescence from 24 h after ACM application;
7DIV neurons treated chronically for 3 days with the diverse
ACMs resulted in robust levels of ROS/RNS (∼70–80% DCF
fluorescence relative to H2O2) (Supplementary Figure 3). We
next analyzed whether the doses of anti-oxidants that effec-
tively increased cell survival (as shown in Figure 3) also pre-
vented the increase in ROS/RNS levels induced by the diverse
ACMs (Figure 4A). Co-application of ACM-SOD1G93A plus
Trolox (1μM) or eculetin (25μM) to spinal cord cultures
decreased intracellular DCF fluorescence to a degree similar
to that achieved in control cultures (Figure 4B). By contrast,
resveratrol (1μM) slightly, but not significantly, reduced nitrox-
idative stress induced by ACM-SOD1G93A. We also observed
that co-application of Trolox and esculetin with ACM-SOD1G86R
(Figure 4C) or ACM-TDP43A315T (Figure 4D) had similar ben-
eficial effects in preventing nitroxidative stress; however, again,
resveratrol was not effective in significantly reducing the DCF
signal. This negative effect of resveratrol was not due to the
absence of its anti-oxidant capacity; resveratrol reduced DCF
fluorescence induced by H2O2 (200μM for 20min) by ∼50%
(Supplementary Figure 4).
Application of these anti-oxidants to control cultures (not
shown), or to spinal cord cultures treated with either ACM-
NT-Control (not shown) or with ACM-SOD1WT (Figure 4E)
revealed that none of these compounds led to significant decreases
in basal DCF fluorescence intensity. Together, our data indi-
cate that the favorable effects of Trolox and esculetin on
motoneuron survival principally result from counterbalancing
the increases in intracellular levels of ROS induced in neurons
by the toxic actions of ACM-SOD1G93A, ACM-SOD1G86R, or
ACM-TDP43A315T.
FIGURE 3 | Anti-oxidants Trolox and esculetin prevent motoneurons
death induced by ACM-SOD1G93A, ACM-SOD1G86R, and
ACM-TDP43A315T. (A) Flow diagram of experiment. ACMs were applied
(Continued)
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FIGURE 3 | Continued
chronically starting at 4DIV alone, or together with the anti-oxidants Trolox
(1μM), esculetin (25μM), or resveratrol (1μM). Cell survival was assayed
at 7DIV. (B–E) Graphs showing the relative percentage of motoneurons
that survived at 7DIV, after being treated with the diverse anti-oxidants and
ACM-SOD1G93A (B), ACM-SOD1G86R (C), ACM-TDP43A315T (D), or
ACM-SODWT (E), relative to motoneurons from sister cultures treated with
control medium (indicated with*) or with only the ACM (indicated with#).
Note that Trolox and esculetin prevented motoneuron death induced by the
diverse ALS-causing ACMs, while resveratrol was ineffective. Note also that
none of the compounds improved the survival of control neurons. Values
represent means ± s.e.m. from at least 3 independent experiments,
analyzed by One-Way ANOVA followed by a Tukey post-hoc test. ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001 relative to survival with control media at 7DIV;
##P < 0.01 and ###P < 0.001 compared to survival with ALS-causing ACM
at 7DIV. See Supplementary Table 1. for the effects of a wide range of
concentrations of anti-oxidants on motoneuron survival.
NaV CHANNEL BLOCKERS RESCUE MOTONEURON DEATH INDUCED
BY ACM-SOD1G93A, OR ACM-TDP43A315T
To gain insights into the mechanism whereby astrocytes
expressing diverse ALS-causing mutant proteins increase intra-
cellular ROS/RNS levels and kill motoneurons, we argued that
if the conditioned media from the SOD1 and TDP43 mutant
astrocytes share a toxic factor(s), then this toxicity must converge
to a common target. We recently reported that ACM-SOD1G93A
rapidly (within 30min) increases neuronal Nav channel medi-
ated excitability; moreover, the application of several blockers of
the Nav channel activity (including use of mexiletine, spermi-
dine, and riluzole) reduced the hyperexcitability and prevented
motoneuron death induced by ACM-SOD1G93A (Fritz et al.,
2013). Hence we tested whether the Nav channel blocker mex-
iletine (an orally active lidocaine analog that is a local anesthetic
and an antiarrhytmic drug that targets the “local anesthetic
receptor site” of Nav channels (Ragsdale et al., 1994; Catterall
et al., 2005; Olschewski et al., 2009), spermidine (a polyamine
that affects the gating of varies ion channels and serves as an
endogenous, activity-dependent Nav channel blocker (Williams,
1997; Fleidervish et al., 2008) and riluzole which has multiple
effects, but at low concentrations (e.g., 100 nM in spinal cord
cultures) suppresses neuronal excitability by affecting Nav chan-
nels (Kuo et al., 2005; Theiss et al., 2007; Bellingham, 2011; Fritz
et al., 2013) can also rescue motoneuron cell death induced by
ACM-SOD1G86R or ACM-TDP43A315T (Figure 5A). We used the
same concentrations of these Nav channel blockers as described
previously: 25 nM mexiletine, 10μM spermidine and 100 nM
riluzole (Fritz et al., 2013)—these doses were chosen based on
earlier determinations that at these concentrations the Nav chan-
nel blockers reduced excitability and also effectively prevented
motoneuron cell death induced by ACM-SOD1G93A, without
affecting overall motoneuron cell survival in control cultures
(Fritz et al., 2013; and see also Figures 5B,E).
To directly compare the beneficial effect of co-application of
mexiletine, spermidine or riluzole on the diverse toxic ACMs, we
first analyzed motoneuronal survival when these sodium chan-
nel blockers were co-applied with ACM-SOD1G93A (Figure 5B).
As expected, chronic application (from 4 to 7DIV) of mex-
iletine together with ACM-SOD1G93A to spinal cord cultures
prevented motoneuron death in those cultures (Figure 5B),
FIGURE 4 | The effect of anti-oxidants on DCF fluorescence in spinal
cord cultures exposed to the diverse ACMs. (A) Flow diagram of
experiment. ACMs were applied chronically starting at 4DIV alone, or
(Continued)
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FIGURE 4 | Continued
together with the anti-oxidants Trolox (1μM), esculetin (25μM), or
resveratrol (1μM). At 7DIV, cultures were incubated with the membrane
permeable ROS/RNS probe CM-H2DCF-DA and DCF fluorescence was
measured 30min later. (B–E) Graphs showing the percentage of DCF
fluorescent cells after being treated with the diverse anti-oxidants and
ACM-SOD1G93A (B), ACM-SOD1G86R (C), ACM-TDP43A315T (D), or
ACM-SODWT (E), In all experiment, H2O2 (200μM for 20min) served as
positive control and to normalize the number of DCF-positive cells after
ACM application. The graphs indicate statistics relative to motoneurons
from sister cultures treated with control medium (indicated with∗) or with
only the ACM (indicated with#). Note that co-application of the diverse
ACMs with Trolox or esculetin resulted in significant lower DCF fluorescent
intensities, whereas resveratrol was not effective. Values represent means
± s.e.m. from at least 3 independent experiments, analyzed by One-Way
ANOVA followed by a Tukey post-hoc test. ∗∗P < 0.01, ∗∗∗P < 0.001 relative
to DCF fluorescence with control media at 7DIV; ##P < 0.01 and
###P < 0.001 compared to DCF fluorescence with ALS-causing ACM at
7DIV.
as we have shown earlier (Fritz et al., 2013). Addition of
mexiletine to spinal cord cultures exposed to ACM-SOD1G86R
(Figure 5C) and ACM-TDP43A315T (Figure 5D) was also very
beneficial and resulted in partially or complete prevention
of motoneuron cell death, respectively. Spermidine (10μM)
also completely rescued motoneuron from death induced by
ACM-SOD1G93A (Figure 5B), ACM-SOD1G86R (Figure 5C), or
ACM-TDP43A315T (Figure 5D). And furthermore chronic co-
incubation of spinal cord cultures with 100 nM riluzole and
ACM-SOD1G93A (Figure 5B) or ACM-SOD1G86R (Figure 5C)
completely prevented motoneuron death. The beneficial effects
of this drug were less apparent on motoneurons incubated with
ACM-TDP43A315T (Figure 5D).
NaV CHANNEL BLOCKERS PREVENT INCREASES IN NITROXIDATIVE
STRESS INDUCED BY ACM-SOD1G93A, ACM-SOD1G86R, OR
ACM-TDP43A315T
To determine whether the Nav channel-mediated hyperexcitabil-
ity occurs upstream or downstream of the nitroxidative stress
detected by DCF, we co-applied the diverse ACMs with Nav chan-
nel blockers to 4DIV cultures and measured the intensity of DCF
fluorescence (Figure 6A). The incubation time of the Nav chan-
nel blockers with the ACMs was chosen based on the maximum
peak in the established time-course of DCF fluorescence for each
conditioned media (see Figure 2): ACM-SOD1G93A and ACM-
TDP43A315T were tested at 30min, whereas ACM-SOD1G86R
was tested at 60min. We found that all three Nav channel
blockers significantly reduced DCF fluorescence induced by the
diverse ACMs, but to different degrees: mexiletine and sper-
midine reduced the DCF fluorescent signal induced by ACMs-
SOD1G93A to a level similar to that achieved in untreated cultures,
while riluzole decreased DCF fluorescence to below basal levels
(Figure 6B). Similar effects were observed when these Nav chan-
nel blockers were co-applied with ACM-SOD1G86R (Figure 6C),
ACM-TDP43A315T (Figure 6D), or ACM-SOD1WT (Figure 6E).
Collectively, these data indicate that astrocytes expressing diverse
ALS-causing mutant genes, including in the alleles SOD1 and
TDP43, secrete soluble factors that kill wild-type motoneurons
FIGURE 5 | Nav channel blockers prevent motoneuron death induced
by ACM-SOD1G93A, ACM-SOD1G86R, and ACM-TDP43A315T. (A)
Flow diagram of experiment. ACMs were applied chronically starting at 4DIV
(Continued)
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FIGURE 5 | Continued
alone, or together with the Nav channel blockers mexiletine (25 nM),
spermidine (10μM), or riluzole (100 nM). Cell survival was assayed at 7DIV.
(B–E) Graphs showing the relative percentage of motoneurons that
survived at 7DIV, after being treated with the diverse Nav channel blockers
and ACM-SOD1G93A (B), ACM-SOD1G86R (C), ACM-TDP43A315T (D), or
ACM-SOD1WT (E), relative to motoneurons from sister cultures treated
with control medium (indicated with∗) or with only the ACM (indicated
with#). Values represent means ± s.e.m. from at least 3 independent
experiments, analyzed by One-Way ANOVA followed by a Tukey post-hoc
test. ∗P < 0.05, ∗∗∗P < 0.001 relative to survival with control media at
7DIV; ##P < 0.01 and ###P < 0.001 compared to survival with ALS-causing
ACM at 7DIV.
through a common pathway that involves increased nitroxidative
stress, mediated at least in part by Nav channel activity.
DISCUSSION
We provide evidence to demonstrate that astrocytes express-
ing mutations in SOD1 and TDP43 genes trigger motoneuron
pathology and death through non-cell-autonomous processes
mediated by the release of soluble toxic factor(s). We show that
conditioned media derived from astrocytes that express ALS-
causing mutations in SOD1 (SOD1G93A and SOD1G86R) and
TDP43 (TDP43A315T) enhance ROS/RNS levels in neurons, and
reduce motoneuron survival. We also document that application
of anti-oxidants to spinal cord cultures prevents the increases
in intracellular nitroxidative stress induced by diverse ACMs,
and counteracts motoneuron death induced by the toxins in
these media. Our finding that addition of Nav channel block-
ers to spinal cord cultures also strongly diminish ACM-induced
enhancement of DCF fluorescence andmotoneuron death further
indicates that Nav channel-mediated excitability occurs upstream
of nitroxidative stress and is required for the generation of a cer-
tain type of such stress. Collectively, these results indicate that
astrocytes that express ALS-causing mutants in SOD1 and TDP43
contribute to ALS pathogenesis by activating a common molecu-
lar pathway that involves nitroxidative stress mediated, at least in
part, by Nav channel activity.
MUTATIONS IN SOD1 AND TDP43 CAUSE MOTONEURON PATHOLOGY
AND DEATH BY NON-CELL-AUTONOMOUS PROCESSES
Ample evidence reveals that astrocytes expressing SOD1 mutants
contribute to the pathogenesis of ALS: we and others have also
demonstrated that such astrocytes release neurotoxic factors that
kill primary motoneurons in culture (Nagai et al., 2007; Cassina
et al., 2008; Castillo et al., 2013; Fritz et al., 2013). In agreement
with these studies, we show here that ACM-SOD1G93A and ACM-
SOD1G86R also extensively and selectively kill primary motoneu-
rons. Additionally, we also examined whether mutants in TDP43
contribute to disease pathogenesis by non-cell-autonomous pro-
cesses. As for ACM-SOD1G93A and ACM-SOD1G86R, we docu-
ment that exposure of wild-type spinal cord cultures to condi-
tioned media generated by astrocytes derived from transgenic
mice that express mutant TDP43A315T suffices to trigger robust
death of motoneurons. These data indicate that astrocytes har-
boring mutant TDP43A315T release soluble toxic factor(s) into
the media and thereby contribute to disease pathogenesis via
non-cell-autonomous processes.
FIGURE 6 | Nav channel blockers reduce DCF fluorescence induced by
ACM-SOD1G93A, ACM-SOD1G86R, and ACM-TDP43A315T. (A) Flow
diagram of experiment. Spinal cultures (4 DIV) were exposed for 30
(Continued)
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FIGURE 6 | Continued
(ACM-SOD1G93A or ACM-TDP43A315T) or 60 (ACM-SOD1G86R) minutes (see
Figure 2 for peak of DCF fluorescence), alone or together with Nav channel
blockers mexiletine (25 nM), spermidine (10μM), or riluzole (100 nM). Next,
cultures were incubated with the membrane permeable ROS/RNS probe
CM-H2DCF-DA and DCF fluorescence was measured 30min later. (B–E)
Graphs showing the percentage of DCF fluorescent cells after being
treated with the diverse Nav channel blockers and Nav channel blockers
and ACM-SOD1G93A (B), ACM-SOD1G86R (C), ACM-SODWT (D),
ACM-TDP43A315T (E). In all experiment, H2O2 (200μM for 20min) served
as positive control and to normalize the number of DCF-positive cells after
ACM application. The graphs indicate statistics relative to motoneurons
from sister cultures treated with control medium (indicated with∗) or with
only the ACM (indicated with#). Values represent means ± s.e.m. from at
least 3 independent experiments, analyzed by One-Way ANOVA followed
by a Tukey post-hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 relative to
DCF fluorescence with control media at 7DIV; ##P < 0.01 and ###P < 0.001
compared to DCF fluorescence with ALS-causing ACM at 7DIV.
Our findings are in contrast to a recent publication by Serio
et al. (2013), who showed that astrocytes expressing mutant
TDP43M337Vcontribute to ALS pathology exclusively via cell-
autonomous processes, and do not via non-cell-autonomous tox-
icity. These authors generated astrocytes from induced pluripo-
tent stem cells (IPSCs) derived from a human ALS patient
carrying the TDP43M337V mutation. They report that expres-
sion of the TDP43 mutant reduced survival of the human
astrocytes, but that co-culturing layers of these TDP43M337V
mutant containing astrocytes with wild-type motoneurons does
not lead to motoneuron death. The reason(s) underlying the
difference between their results and ours may be related to tech-
nical issues associated with the generation of astrocyte popula-
tions from human IPSCs, or to the particular TDP43 mutant
involved. Additional experiments on the effects that diverse
TDP43 mutants expressed in primary rodent astrocytes, as well
as in human IPSCs cell lines, have on motoneurons are needed to
resolve this discrepancy.
EXPOSURE OF MOTONEURONS TO ACM FROM ASTROCYTES
CARRYING MUTATIONS IN SOD1 AND TDP43 ACTIVATES A COMMON
PATHOGENIC PATHWAY
Several hypotheses, involving the influence of nitroxidative
stress, glutamate excitotoxicity, hyperexcitability, formation of
high-molecular-weight aggregates, mitochondrial dysfunction,
cytoskeletal disruption, and activation of cell death signals, have
been proposed to explain the toxic effect of mutated SOD1
(Beckman et al., 2001; Cleveland and Rothstein, 2001; Bruijn
et al., 2004; Pasinelli and Brown, 2006; Cozzolino et al., 2012;
van Zundert et al., 2012). Our results point to critical roles
for nitroxidatve stress as well as Nav channel activity in induc-
ing motoneuron death. We and others have previously used cell
cultures and slice preparations obtained from transgenic mice
expressing mutations in SOD1 to report that Nav channel activity
and/or excitability is increased in motoneurons (Kuo et al., 2005;
van Zundert et al., 2008; Pambo-Pambo et al., 2009; Pieri et al.,
2009; Schuster et al., 2011; Quinlan et al., 2011 and reviewed in
ElBasiouny et al., 2010 and van Zundert et al., 2012). Moreover,
using the ACM-SOD1G93A model system, we recently found that
neuronal hyperexcitability, mediated at least in part through
elevated Nav channel activity, is essential for inducing motoneu-
ron death. And furthermore, the data presented here indicate
that soluble factor(s) secreted by astrocytes carrying other ALS-
causing mutations in SOD1 (SODG86R), and moreover in TDP43
(TDP43A315T), kill motoneurons via activation of Nav channels.
Soluble mediator(s) secreted by astrocytes with mutations in
SOD1 and TDP43 rapidly enhance neuronal nitroxidative stress,
andleadtoextensivemotoneurondeathwithinamatterofdays.The
rapid elevation in ROS/RNS levels observed in neurons exposed
to the toxic ACMs could be due to diffusion of nitroxidative
stress generated outside the cell into the motoneurons, or via
intracellular de novo generation of ROS/RNS.We favor the second
option, as the robust increase in the intensity of DCF fluorescence
in motoneurons upon application of toxic ACMs is abolished
when Nav channel blockers are applied to the spinal neuron
cultures. Note, however, that it has been documented that DCF
detects only particular types of reactive species, including hydro-
gen peroxide (H2O2; in combination with cellular peroxidases),
hydroxyl radicals (•OH), and peroxynitrite (ONOO−) (Estévez
et al., 1999; Myhre et al., 2003; Gomes et al., 2005; Martin et al.,
2007; Kalyanaraman et al., 2012), while it is seems insensitive to
nitric oxide (NO) and superoxide (O2•−) (Myhre et al., 2003). It is
thus possible that neurons are targets of certain ROS/RNS, includ-
ing externalNOorO2•−, that contribute to neuronal nitroxidative
stress without being detected by the DCF probe.
With regard to this idea, amply evidence indicates that NO
and O2•− are produced by ALS glial cells—as a result of either
mitochondrial dysfunction, increased NADPHoxidase activity, or
inflammation—and play a pivotal role in motoneuron pathology
and death (Carter et al., 2009; Drechsel et al., 2012). For exam-
ple, Barbeito and collaborators (Vargas et al., 2006; Cassina et al.,
2008) report that 40% of motoneurons are lost when they are
co-cultured on astrocytes carrying mutated SOD1G93A and that
these astrocytes were found to produce excessive levels of NO
and mitochondrial O2•−. Moreover, cell death is abrogated when
these astrocytes are pre-treated with either anti-oxidants capable
of reducing O2•− production, or with inhibitors of NO syn-
thase (NOS) (Vargas et al., 2006; Cassina et al., 2008). Additional
studies also indicate that astrocytes and microglia that express
mutated SOD1 can generate NO and NADPH oxidase (Nox)-
derived ROS (Harraz et al., 2008; Marchetto et al., 2008). Also,
in vivo production of harmful Nox-derived O2•− is reported
in human SALS patients as well as in the SOD1G93A transgenic
mouse model (Wu et al., 2006; Marden et al., 2007; Harraz et al.,
2008). And finally, recent studies indicate that even extracellu-
lar mutant SOD1 and oxidized/misfolded SOD1 protein (both
of which are likely to be secreted by cells) can activate microglia
and induce nitroxidative stress (Urushitani et al., 2006; Ezzi et al.,
2007; Zhao et al., 2010). Based on these studies, it is plausible
that wild-type neurons are targets of external NO or O2•− that
(1) accumulates in media conditioned by astrocytes carrying ALS
mutants, or (2) is generated by surrounding wild-type glial cells
(astrocytes and/or microglia) within the spinal cord culture via
the action of factors present in the ACM (such as mutated or
oxidized/misfolded SOD1 that is secreted by the ALS astrocytes).
The presence of these RNS/ROS not necessarily affects externally
positioned molecules located in or on the cell membranes of
neurons: Thus, NO freely diffuses across cell membranes, and
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 24 | 11
Rojas et al. Nav -channel activity and ROS/RNS in ALS models
whereas membranes are relatively impermeable to O2•−, recent
studies indicate that this oxidative specie could permeate across
redoxosomal membranes through undefined chloride channels
(Mumbengegwi et al., 2008; Carter et al., 2009). On the basis of
our findings presented here and in previous studies, we support
the view that induction of Nav channel activation by toxic ACMs
is a central factor in initiating motoneuron death in ALS (van
Zundert et al., 2012; Fritz et al., 2013). Nav channel activity can be
increased directly by different oxidative species (Hammarström
and Gage, 2000; Kassmann et al., 2008; Nani et al., 2010), but
also indirectly by other factors such kinases (e.g., PKC) and
the Nav channel β-subunits (Franceschetti et al., 2000; Goldin,
2003; Aman et al., 2009). It would be interesting to define by
mutagenesis whether oxidation of particular amino acids residues
(especially methionines and cysteines) influence Nav channel
activation; these types of experiments, however, are beyond the
scope of this study.
Here we present the following hypothesis to reconcile the stud-
ies by others and the data we have present here and previously
(Fritz et al., 2013) showing that ACM-SOD1G93A rapidly (30min)
increases the frequency of calcium transients in cultured spinal
cord neurons. Conditioned media derived from astrocytes carry-
ing SOD1 and TDP43 mutants contains NO and/or leads to the
generation of NO in spinal cord cultures. This NO in turn induces
the activation of Nav channels, leading to excessive calcium
influxes through activated Cav channels; the calcium-mediated
activation of mitochondrial respiratory chain complexes and/or
Nox complexes will produce intracellular O2•− that can interact
with NO to spontaneously generate ONOO− that hence can be
detected by DCF and promotes intracellular damage, including
protein nitration (Beckman et al., 2001; Cleveland and Rothstein,
2001; Martin et al., 2007). This hypothesis is supported by the
fact that limiting the levels of O2•− by either reducing Nox activ-
ity (Wu et al., 2006; Harraz et al., 2007) or by application of
compounds such as Trolox and esculetin (in this study), which
have antioxidant and free radical scavenger capacities (Barber
et al., 2009), prevented motoneuron death in diverse ALS mod-
els. The finding that the antioxidant resveratrol, unlike Trolox
and esculetin, was unable to significantly prevent ACM-induced
motoneuron death can be explained by the fact that this com-
pound is a poor free radical scavenger compared to the other two
compounds (Barber et al., 2009).
DO SOLUBLE TOXIC FACTOR(S) RELEASED BY ALS ASTROCYTES
SPECIFICALLY TARGET MOTONEURONS?
Data presented here and previously (Vargas et al., 2006; Di
Giorgio et al., 2007; Nagai et al., 2007; Cassina et al., 2008;
Marchetto et al., 2008; Castillo et al., 2013; Fritz et al., 2013)
show compelling evidence that whereas astrocytes expressing
ALS-linked mutations kill motoneurons in spinal cord cultures,
they do not affect the survival of spinal cord interneurons. Data
shown here and previously (Castillo et al., 2013; Fritz et al.,
2013) indicate that independent of neuronal degeneration expo-
sure of spinal cord cultures to toxic ACMs causes pathophysio-
logical changes—including increases in nitroxidative stress, Nav
channel activity, neuronal excitability, and intracellular calcium
transients—in both motoneurons and interneurons. Moreover,
detailed analyses in SOD1-ALS mice also indicate that several
pathological changes can be detected in interneurons, and impor-
tantly, much before the onset of disease symptoms (Martin et al.,
2007; van Zundert et al., 2008, 2012; Ramírez-Jarquín et al., 2013;
Wootz et al., 2013). If both types of neurons are affected in ALS,
why then are motoneurons killed and interneurons spared? Using
electrophysiological recordings, we recently showed (Fritz et al.,
2013) that application of ACM-SOD1G93A significantly increased
the persistent sodium inward current (PCNa) of neurons; this
PCNa is mediated by Nav channels (PCNa is greater for Nav1.1 and
Nav1.6 as compared to Nav1.2 and Nav1.3), and small increases
can have important effects on neuronal excitability, leading to
excessive influxes of calcium and sodium (ElBasiouny et al., 2010;
van Zundert et al., 2012). Interestingly, we found that neurons
with a large soma (>20μm diameter) and expressing ≥5 pri-
mary dendrites (typical for motoneurons) displayed a larger PCNa
compared to neurons with a smaller soma (<20μm diameter)
and expressing ≤4 primary dendrites (typical for interneurons).
Moreover, application of ACM-SOD1G93A further increased the
PCNa of neurons, especially of motoneurons. The expression of
specific Nav channel subtypes, and subsequent activation of these
channels by soluble toxic factor(s) released by ALS astrocytes,
will thus induce larger PCNa and in turn cause more sustained
calcium influxes in motoneurons compared to interneurons. In
addition, because motoneurons have a limited cytosolic calcium-
buffering capacity, excessive uptake of calcium by mitochondria
would be an initial step in a cascade of events that impair mito-
chondrial function, thereby likely producing excessive O2•− that
ultimately leads to motoneuron death (von Lewinski and Keller,
2005; Bento-Abreu et al., 2010; van Zundert et al., 2012).
In summary, we have elucidated critical roles for both nitrox-
idative stress and Nav channel activation in the death of motoneu-
ron that is induced in diverse ALS models. Finally, because
patients with SALS and FALS display a similar pathology, have
comparable clinical symptoms that include hyperexcitability, and
experience a beneficial effect of riluzole, it is possible that diverse
Nav channel blockers will show benefit in both forms of ALS.
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Supplementary Figure 1 | Exposure of primary spinal cord cultures to
Control media or ACM-NT-Control media does not induce increases in
intracellular DCF fluorescence. (A) Flow diagram of experiment. Primary
wild-type spinal cultures (4DIV) were exposed for 0–120min with the
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different medias (solid lines), washed to remove the ACMs (filled circles),
and loaded for 30min with the fluorescent membrane permeable
ROS/RNS probe CM-H2DCF-DA (dotted lines). Next, cultures were washed
and DCF measurements were immediately performed (filled triangles).
(B–D) Cultures were exposed to three types of control media: “Control”
media that was not conditioned by astrocytes (B), “ACM-SOD1WT” media
derived from astrocytes that were harvested from transgenic mice
carrying the non-pathological human wild-type SOD1 gene (C), and
“ACM-NT-Control” media derived from astrocytes that were harvested
from littermate mice that were negative for the mutant SOD1 or TDP43
gene; here we show media from TDP43A315T−/− astrocytes. Similar
results were obtained after application of media from SOD1G93A−/− or
SOD1G86R−/− astrocytes (D). The negatives of representative DCF
fluorescent images (in which both motoneurons and interneurons are
marked) and corresponding phase contrast images of spinal cord cultures
photographed at the different indicated time points of media application
are shown. Note that unlike H2O2 (200μM for 20min), which served as a
positive control (shown in B in the right), none of the control media
induced increases in intracellular DCF fluorescence. Scale bar, 200μm.
Supplementary Figure 2 | Time-course of motoneuron survival in primary
spinal cord cultures exposed to ACM-SOD1G93A. Primary wild-type (WT) rat
spinal cord cultures (4DIV) were exposed for 2, 8, 24, and 72 h to ACM
derived from transgenic mice overexpressing SOD1G93A (ACM-SOD1G93A)
and fixed immediately afterwards. Cell survival was assayed with
immunocytochemistry. Graph showing the percentage of motoneurons
that survived after treatment with ACMSOD1G93A, relative to control
medium and with media derived from transgenic mice carrying the
non-pathological human wild-type SOD1 gene (ACM-SOD1WT). Survival is
shown relative to cultures treated with control media. Values represent
mean ± s.e.m. from at least 3 independent experiments performed in
duplicate, analyzed by One-Way ANOVA followed by a Tukey post-hoc
test. ∗∗∗P < 0.001 relative to control medium at 7DIV.
Supplementary Figure 3 | Time-course of DCF fluorescence in spinal cord
cultures exposed to ACM-SOD1G93A, ACM-SOD1G86R, or ACM-TDP43A315T.
(A) Flow diagram of experiment. Primary wild-type spinal cultures (4DIV)
were exposed for 0, 30, 60, 90, and 120min and 6, 24, 48, and 72 h with
the different ACMs (solid lines), washed to remove the ACMs (filled
circles), and loaded for 30min with the fluorescent membrane permeable
ROS/RNS probe CM-H2DCF-DA (dotted lines). Next, cultures were
washed and DCF measurements were immediately performed (filled
triangles). (B–D) Graphs showing the percentage of DCF fluorescent cells
(including both motoneurons and interneurons) in cultures exposed to
ACM-SOD1G93A (B), ACM-SOD1G86R (C), or ACM-TDP43A315T (D).
Results obtained with different controls are included in the graphs:
ACMSOD1WT (B), ACM-NT-Control from SOD1G86R−/−astrocytes (C), and
ACM-NT-Control from TDP43A314T−/− astrocytes (D). DCF fluorescence is
relative to cultures treated with H2O2, 200μM for 20min (100%). Note
that application of toxic ACMs resulted in an initial peak of DCF
fluorescence at 30–60min that was followed by a decline in the DCF
signal which then started to steadily increase from 24h on. Values
represent mean ± s.e.m. from at least 3 independent experiments
performed in duplicate, analyzed by t-test. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001 vs. control.
Supplementary Figure 4 | Anti-oxidant resveratrol is as effective as Trolox
and esculetin in reducing DCF fluorescence induced by H2O2. (A) Flow
diagram of experiment. Primary spinal cord cultures (4DIV) were exposed
to 200μM H2O2 for 20min in the presence or absence of anti-oxidants.
Cells were washed and then loaded with the membrane permeable
ROS/RNS probe CM-H2DCF-DA for 30min. After washing, DCF
fluorescence was measured immediately. (B) Graphs showing the
percentage of DCF fluorescent cells (including motoneurons and
interneurons) in cultures exposed to H2O2 and Trolox (1μM), esculetin
(25μM), or resveratrol (1μM). Values represent means ± s.e.m. from at
least 3 independent experiments, analyzed by One-Way ANOVA followed
by a Tukey post-hoc test. ##P < 0.01, ###P < 0.001 relative to DCF
fluorescence in H2O2 treated cultures.
Supplementary Table 1 | Effects of a wide range of concentrations of
antioxidants on the survival of control motoneurons and those exposed to
ACM-SOD1G93A. (A) Analysis of survival of motoneurons at 7DIV in
primary cultures after incubation for 4 days with multiple doses of the
anti-oxidants Trolox, esculetin, and resveratrol. (B) Analysis of surviving
motoneurons at 7DIV in primary cultures after incubation for 4 days with
ACM-hSOD1G93A alone (no drug), or with ACM plus different doses of the
anti-oxidants. In bold are indicated concentrations at which concentration
the anti-oxidant was selected for further analysis on preventing the
toxicity induced by the diverse ACMs; those results are displayed in
Figure 3. Values represent mean ± s.e.m. from at least 3 independent
experiments performed in duplicate, analyzed by t-test vs. control.
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